Inactivation of CD11b in a mouse transgenic model protects against sepsis-induced lung PMN infiltration and vascular injury
- 14 April 2005
- journal article
- Published by American Physiological Society in Physiological Genomics
- Vol. 21 (2), 230-242
- https://doi.org/10.1152/physiolgenomics.00291.2004
Abstract
To inactivate chronically the β2-integrin CD11b (Mac-1), we made a transgenic model in mice in which we expressed the CD11b antagonist polypeptide neutrophil inhibitory factor (NIF). Using these mice, we determined the in vivo effects of CD11b inactivation on polymorphonuclear leukocyte (PMN) function and acute lung injury (ALI) induced by Escherichia coli septicemia. In wild-type PMNs, CD11b expression was induced within 1 h after E. coli challenge, whereas this response was significantly reduced in NIF+/+PMNs. Coimmunoprecipitation studies showed that NIF associated with CD11b in NIF+/+PMNs. To validate the effectiveness of CD11b blockade, we compared PMN function in NIF+/+and Mac-1-deficient (Mac-1−/−) mice. Adhesion of both Mac-1−/−and NIF+/+PMNs to endothelial cells in response to LPS was reduced in both types of PMNs and fully blocked only by the addition of anti-CD11a monoclonal antibody. This finding is indicative of intact CD11a function in the NIF+/+PMNs but the blockade of CD11b function. CD11b inactivation in NIF+/+mice interfered with lung PMN infiltration induced by E. coli and prevented the increase in lung microvessel permeability and edema formation, with most of the protection seen in the 1-h period after the E. coli. Thus our results demonstrate that CD11b plays a crucial role in mediating lung PMN sequestration and vascular injury in the early phase of gram-negative septicemia. The NIF+/+mouse model, in which CD11b is inactivated by binding to NIF, is a potentially useful model for in vivo assessment of the role of PMN CD11b in the mechanism of vascular inflammation.Keywords
This publication has 39 references indexed in Scilit:
- A Molecular Basis for Integrin αMβ2 Ligand Binding PromiscuityPublished by Elsevier BV ,2002
- The Link Module from Human TSG-6 Inhibits Neutrophil Migration in a Hyaluronan- and Inter-α-inhibitor-independent MannerPublished by Elsevier BV ,2002
- A whole-blood flow cytometric assay for leukocyte CD11b expression using fluorescence signal triggeringEuropean Journal of Haematology, 2000
- Mice Deficient in Mac-1 (CD11b/CD18) Are Less Susceptible to Cerebral Ischemia/Reperfusion InjuryStroke, 1999
- A Role for Mac-1 (CDIIb/CD18) in Immune Complex–stimulated Neutrophil Function In Vivo: Mac-1 Deficiency Abrogates Sustained Fcγ Receptor–dependent Neutrophil Adhesion and Complement-dependent Proteinuria in Acute GlomerulonephritisThe Journal of Experimental Medicine, 1997
- Neutrophil Emigration in the Skin, Lungs, and Peritoneum: Different Requirements for CD11/CD18 Revealed by CD18-deficient MiceThe Journal of Experimental Medicine, 1997
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversityCell, 1991
- High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets.The Journal of cell biology, 1989
- Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen.The Journal of cell biology, 1988